Marshall & Sullivan Inc. WA lowered its holdings in Procter & Gamble Co (NYSE:PG) by 15.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,619 shares of the company’s stock after selling 294 shares during the period. Marshall & Sullivan Inc. WA’s holdings in Procter & Gamble were worth $202,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. AMI Asset Management Corp grew its position in Procter & Gamble by 0.7% during the third quarter. AMI Asset Management Corp now owns 13,431 shares of the company’s stock valued at $1,671,000 after purchasing an additional 87 shares in the last quarter. Centric Wealth Management grew its position in Procter & Gamble by 0.9% during the third quarter. Centric Wealth Management now owns 10,692 shares of the company’s stock valued at $1,295,000 after purchasing an additional 91 shares in the last quarter. First Mercantile Trust Co. grew its position in Procter & Gamble by 1.5% during the third quarter. First Mercantile Trust Co. now owns 6,164 shares of the company’s stock valued at $767,000 after purchasing an additional 92 shares in the last quarter. Earnest Partners LLC grew its position in Procter & Gamble by 8.0% during the second quarter. Earnest Partners LLC now owns 1,296 shares of the company’s stock valued at $142,000 after purchasing an additional 96 shares in the last quarter. Finally, Southeast Asset Advisors Inc. grew its position in Procter & Gamble by 1.7% during the second quarter. Southeast Asset Advisors Inc. now owns 5,858 shares of the company’s stock valued at $642,000 after purchasing an additional 96 shares in the last quarter. 62.74% of the stock is currently owned by institutional investors.

In other news, CEO Ma. Fatima Francisco sold 1,729 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $122.00, for a total value of $210,938.00. Following the completion of the sale, the chief executive officer now directly owns 6,856 shares in the company, valued at $836,432. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Nelson Peltz sold 936,280 shares of the business’s stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $123.87, for a total transaction of $115,977,003.60. Following the completion of the sale, the director now owns 3,844 shares of the company’s stock, valued at $476,156.28. The disclosure for this sale can be found here. Insiders sold 1,288,513 shares of company stock valued at $159,734,252 over the last 90 days. 1.75% of the stock is owned by corporate insiders.

A number of analysts have issued reports on the stock. Morgan Stanley lifted their target price on shares of Procter & Gamble from $130.00 to $134.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Macquarie lifted their target price on shares of Procter & Gamble from $132.00 to $138.00 and gave the company an “outperform” rating in a research note on Wednesday, October 23rd. ValuEngine cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. JPMorgan Chase & Co. lifted their target price on shares of Procter & Gamble from $136.00 to $139.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Finally, TheStreet upgraded shares of Procter & Gamble from a “c+” rating to a “b+” rating in a research note on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $119.07.

Shares of Procter & Gamble stock traded down $0.32 on Tuesday, reaching $124.56. The stock had a trading volume of 3,752,451 shares, compared to its average volume of 6,050,911. The business’s 50-day moving average price is $124.03 and its two-hundred day moving average price is $120.26. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.54 and a current ratio of 0.72. Procter & Gamble Co has a fifty-two week low of $89.08 and a fifty-two week high of $126.60. The stock has a market cap of $309.16 billion, a P/E ratio of 27.56, a price-to-earnings-growth ratio of 3.36 and a beta of 0.40.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Tuesday, October 22nd. The company reported $1.37 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.13. Procter & Gamble had a net margin of 6.24% and a return on equity of 25.07%. The business had revenue of $17.80 billion during the quarter, compared to analysts’ expectations of $17.43 billion. During the same period in the previous year, the company earned $1.12 earnings per share. Procter & Gamble’s revenue for the quarter was up 6.6% on a year-over-year basis. As a group, equities analysts forecast that Procter & Gamble Co will post 4.94 earnings per share for the current fiscal year.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Read More: How is the LIBOR rate calculated?

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.